Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.
Department of Medicine, University of California, San Francisco, San Francisco, CA.
JCO Oncol Pract. 2023 Jul;19(7):465-472. doi: 10.1200/OP.22.00830. Epub 2023 May 15.
To determine the prevalence of attrition and the frequency of transition from a primarily clinical role to an industry-related role among oncology physicians.
We tracked yearly Centers for Medicare & Medicaid Services (CMS) billing between 2015 and 2022 to estimate attrition of oncology physicians. A subanalysis of a random sample of 300 oncologists with fewer than 30 years of experience and who had stopped billing were used to conduct a more thorough assessment of current employment. Employment was primarily found through LinkedIn; otherwise a secondary search was done through a Google search. Type of employer was categorized as industry (pharmaceutical or biotechnology), nonindustry (academic/clinical/government), others, or no information found. The results are provided separately by sex.
Of the 16,870 oncologists who billed to CMS in 2015, 3,558 (21%) had stopped billing by 2022. Among a randomly selected 300 oncologists, we found current employment information for 223 (74%); 78 of the 223 (35%) were most recently employed within industry. Among all CMS-billing oncologists, 30% (5,126 of 16,870) identified as female. Women stopped billing at the rate of 18% (929 of 5,126) by 2022. Surgical oncologists had the lowest overall attrition (17%, 149 of 855). Radiation oncologists had 21% (881 of 4,244) overall attrition and 7% (5 of 71) sampled attrition to industry.
By 2022, 21% of oncology physicians billing to CMS in 2015 had stopped. 78 of the 300 sampled physicians were found to be working in industry. In total, 1 in 17 oncologists (5%) moved to industry over a 5-year period.
确定肿瘤医师中离职的比例以及从主要临床角色向与行业相关角色转变的频率。
我们跟踪了 2015 年至 2022 年期间医疗保险和医疗补助服务中心（CMS）的年度计费，以估计肿瘤医师的离职情况。对少于 30 年从业经验且已停止计费的 300 名随机抽取的肿瘤学家进行了子分析，以更全面地评估其当前的就业情况。通过领英查找就业情况；否则，通过谷歌搜索进行二次搜索。雇主类型分为行业（制药或生物技术）、非行业（学术/临床/政府）、其他或未找到相关信息。结果按性别分别提供。
在 2015 年向 CMS 计费的 16870 名肿瘤学家中，有 3558 名（21%）在 2022 年之前停止计费。在随机抽取的 300 名肿瘤学家中，我们找到了 223 名（74%）的当前就业信息；223 名中的 78 名（35%）最近在行业内任职。在所有向 CMS 计费的肿瘤学家中，30%（5126 名，占 16870 名）被认定为女性。截至 2022 年，女性的离职率为 18%（929 名，占 5126 名）。外科肿瘤学家的总体离职率最低（17%，855 名中的 149 名）。放射肿瘤学家的总体离职率为 21%（4244 名中的 881 名），抽样离职率为 7%（71 名中的 5 名）至行业。
截至 2022 年，2015 年向 CMS 计费的肿瘤医师中有 21%已停止计费。在抽取的 300 名医生中，有 78 名发现从事行业工作。在 5 年期间，共有 17 名肿瘤学家（5%）转行进入行业。
